Clinical TrialsSearch results
Number of results: 488
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Efficacy of PEG-IFN alfa-2b plus Ribabirin and HMG-CoA reductase inhibitor combination antiviral therapy ; pilot study
- Chronic hepatitis C
- Hiroshima liver study group
- 2007-05-09
Other
- A combination of prednisolone and mizoribine and a combination of prednisolone, mizoribine, warfarin and dipyridamole for IgA nephropathy with diffuse mesangial prolideration in children:A randomized controlled trial of efficacy and safety
- IgA nephropathy in children
- The Japanese Pediatric IgA Nephropathy of Treatment Study Group
- 2007-05-14
Other
- Phase II study of SMILE chemotherapy for stage IV or relapsed/refractory extranodal NK/T-cell lymphoma
- extranodal NK/T-cell lymphoma, nasal type
- NK-cell Tumor Study Group
- 2007-05-14
Other
- Combination therapy of 5-Fluorouracil/gemcitabine/cisplatin for advanced hepatocellular carcinoma with extrahepatic metastases -A pilot study-
- Hepatocellular carcinoma with extrahepatic metastases
- Hiroshima University
- 2007-05-22
Other
- Efficacy of latanoprost (Xalatan) ophthalmic solution stored at room temperature
- Glaucoma patients
- Hiroshima University Department of Ophthalmology and Visual Science
- 2007-05-31
Other
- Efficacy of rosuvastatin for the treatment of nonalcoholic steatohepatitis with hyperlipidemia
- nonalcoholic fatty liver disease
- Hiroshima University Hospital
- 2007-06-01
Other
- Randomized, double-blind, placebo-controlled study of AMG0001(HGF plasmid) for patients with arteriosclerosis obliterans
- Arteriosclerosis obliterans
- Anges MG, Inc.
- 2007-06-04
Other
- RCC-SNPs Ensuring-study for Leading Eligibility of patients in Cytokine Therapy
- Renal cell carcinoma
- JISG-KC
- 2007-06-04
Other
- Quantification of Epstein-Barr virus DNA in patients undergoing SMILE chemotherapy for stage IV or relapsed/refractory extranodal NK/T-cell lymphoma
- untreated stage IV or relapsed/refractory NK/T-cell lymphoma
- NK-cell Tumor Study Group
- 2007-06-18